Logo image of KCGI

KENSINGTON CAPITAL ACQ-A (KCGI) Stock Fundamental Analysis

NYSE:KCGI - New York Stock Exchange, Inc. - KYG5251K1031 - Common Stock - Currency: USD

11.17  0 (0%)

Fundamental Rating

2

KCGI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. While KCGI seems to be doing ok healthwise, there are quite some concerns on its profitability. KCGI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

KCGI had positive earnings in the past year.
In the past year KCGI has reported a negative cash flow from operations.
KCGI Yearly Net Income VS EBIT VS OCF VS FCFKCGI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 10M 20M

1.2 Ratios

Industry RankSector Rank
ROA 25.71%
ROE 36.88%
ROIC N/A
ROA(3y)8.54%
ROA(5y)N/A
ROE(3y)11.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KCGI Yearly ROA, ROE, ROICKCGI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 10 20

1.3 Margins

KCGI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KCGI Yearly Profit, Operating, Gross MarginsKCGI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

5

2. Health

2.1 Basic Checks

The number of shares outstanding for KCGI has been reduced compared to 1 year ago.
The debt/assets ratio for KCGI is higher compared to a year ago.
KCGI Yearly Shares OutstandingKCGI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M
KCGI Yearly Total Debt VS Total AssetsKCGI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

KCGI has an Altman-Z score of 4.38. This indicates that KCGI is financially healthy and has little risk of bankruptcy at the moment.
KCGI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.38
ROIC/WACCN/A
WACCN/A
KCGI Yearly LT Debt VS Equity VS FCFKCGI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 0.34 indicates that KCGI may have some problems paying its short term obligations.
KCGI has a Quick Ratio of 0.34. This is a bad value and indicates that KCGI is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.34
KCGI Yearly Current Assets VS Current LiabilitesKCGI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

KCGI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.60%, which is quite impressive.
EPS 1Y (TTM)37.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%571.35%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KCGI Yearly Revenue VS EstimatesKCGI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023
KCGI Yearly EPS VS EstimatesKCGI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

KCGI is valuated rather expensively with a Price/Earnings ratio of 18.31.
When comparing the Price/Earnings ratio of KCGI to the average of the S&P500 Index (29.62), we can say KCGI is valued slightly cheaper.
Industry RankSector Rank
PE 18.31
Fwd PE N/A
KCGI Price Earnings VS Forward Price EarningsKCGI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KCGI Per share dataKCGI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KCGI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KENSINGTON CAPITAL ACQ-A

NYSE:KCGI (8/13/2024, 8:16:39 PM)

11.17

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-14 2024-05-14
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap127.78M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.31
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.57
P/tB 3.57
EV/EBITDA N/A
EPS(TTM)0.61
EY5.46%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0
BVpS3.12
TBVpS3.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 25.71%
ROE 36.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)8.54%
ROA(5y)N/A
ROE(3y)11.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.34
Quick Ratio 0.34
Altman-Z 4.38
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%571.35%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-18.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.66%
OCF growth 3YN/A
OCF growth 5YN/A